REQUEST A DEMO
Total
USD $0.00
Search more companies

Myco Medic Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Myco Medic Sdn. Bhd. Profile Updated: January 24, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Myco Medic Sdn. Bhd. is a company in Malaysia, with a head office in Puchong. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on October 17, 2011. There was a net sales revenue increase of 16.34% reported in Myco Medic Sdn. Bhd.’s latest financial highlights for 2023. Its’ total assets recorded a negative growth of 0.14%. In 2023, Myco Medic Sdn. Bhd.’s net profit margin increased by 3.84%.

Headquarters
No. 2A-G, Floor, Jalan Sierra 10/3, Section Sierra 16
Puchong; Selangor; Postal Code: 47120

Contact Details: Purchase the Myco Medic Sdn. Bhd. report to view the information.

Website: http://www.mycomedic.com.my

Basic Information
Registered Capital:
Purchase the Myco Medic Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Myco Medic Sdn. Bhd. report to view the information.
Incorporation Date:
October 17, 2011
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
80%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Myco Medic Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
16.34%
Total operating revenue
16.34%
Operating profit (EBIT)
115.08%
EBITDA
75.35%
Net Profit (Loss) for the Period
125.77%
Total Assets
-0.14%
Total Equity
41.18%
Operating Profit Margin (ROS)
4.44%
Net Profit Margin
3.84%
Return on Equity (ROE)
13.86%
Quick Ratio
4.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?